Cite Filings / ACAD / 0000950170-23-015969

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

ACADIA PHARMACEUTICALS INC Filed 2023-05-01 Acc 0000950170-23-015969

Documents 1

DEF 14A Proxy Statement , acad-20230428.htm

Around this filing

2024-04-26 DEF 14A Proxy Statement
2023-05-02 4 EVP,General Counsel, Secretary sold 917 shares at $21.18 ($19,422)
2023-05-02 4 EVP, COO, Head of Commercial sold 548 shares at $21.18 ($11,607)
2023-05-02 4 CEO sold 7,806 shares at $21.18 ($165,331)
2023-05-01 ARS Annual Report to Security Holders
2023-05-01 DEF 14A Proxy Statement
2022-04-29 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading acad-20230428.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…